Results for tag: "Pseudomonas Aeruginosa Infection"

Pseudomonas Aeruginosa Infection is a type of infection caused by the Gram-negative bacterium Pseudomonas aeruginosa. It is a common cause of hospital-acquired infections, particularly in immunocompromised patients. It is also a major cause of morbidity and mortality in cystic fibrosis patients. Treatment of Pseudomonas Aeruginosa Infection typically involves the use of antibiotics, such as carbapenems, aminoglycosides, and fluoroquinolones. In some cases, combination therapy may be necessary. Infectious Diseases Drugs are used to treat a wide range of infections, including those caused by Pseudomonas Aeruginosa. These drugs are typically administered orally or intravenously, depending on the severity of the infection. They are designed to target the specific bacteria causing the infection, while minimizing the risk of side effects. Some companies in the Pseudomonas Aeruginosa Infection market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more